Mr. William E. Monast is an Executive Vice President Sales and Client Management of Pharmerica Corporationration, since July 2010. He had previously served as Executive Vice President, Operations from April 2009 to June 2010. Prior to joining the Company, Mr. Monast served as Executive Vice President, Sales of Apria Healthcare Group Inc. from September 2007. Mr. Monast joined Apria in 1997 as a regional sales manager in the Northeast. In the ensuing decade, he held responsible roles in both sales and operations in the Northeast and Eastern Divisions. Prior to joining Apria, Mr. Monast served as director of sales for Fresenius Medical Care, a national provider of dialysis and homecare services.
The company has Return on Asset of 5.32 % which means that on every $100 spent on asset it made $5.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.35 % implying that it generated $5.35 on every 100 dollars invested.
The company has 315.5 M in debt with debt to equity (D/E) ratio of 0.71 which is OK given its current industry classification. PharMerica Corporation has Current Ratio of 3.96 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
PharMerica Corporationration operates as an institutional pharmacy services company in the United States. PharMerica Corporation [PMC] is traded on New York Stock Exchange in USA. It is located in Louisville, KY and employs 5,000 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.07%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
